|
Market Closed -
Nasdaq
16:00:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 2.555 USD | -2.85% |
|
-10.04% | +66.99% |
| 08-03 | Compugen Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-03 | Compugen Ltd., Q2 2026 Earnings Call, Aug 03, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 249M | - | - | - | ||
| 50.14B | |||||
| 44.85B | - | - | - | - | - |
| 43.43B | |||||
| 41.14B | |||||
| 32.92B |
- Stock Market
- Stocks
- CGEN Stock
- Charts Compugen Ltd.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
